Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. The company is headquartered in Waltham, Massachusetts and currently employs 2,000 full-time employees. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.
How did RGEN's recent EPS compare to expectations?
The most recent EPS for Repligen Corp is $0.48, beating expectations of $0.39.
How did Repligen Corp RGEN's revenue perform in the last quarter?
Repligen Corp revenue for the last quarter is $0.48
What is the revenue estimate for Repligen Corp?
According to 20 of Wall street analyst, the revenue estimate of Repligen Corp range from $213.57M to $195.65M
What's the earning quality score for Repligen Corp?
Repligen Corp has a earning quality score of B/43.906578. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Repligen Corp report earnings?
Repligen Corp next earnings report is expected in 2026-08-03
What are Repligen Corp's expected earnings?
Repligen Corp expected earnings is $196.12M, according to wall-street analysts.
Did Repligen Corp beat earnings expectations?
Repligen Corp recent earnings of $194.25M does not beat expectations.